Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 3 minute read Pharma Industry News How does Amplia’s ACCENT trial compare to MPACT and POLO in pancreatic cancer response rates? Amplia’s pancreatic cancer trial hits a 31% response rate, surpassing MPACT. Find out how it compares to POLO and what it means for future therapy options. byPallavi MadhirajuJuly 17, 2025